ROIVANT SCIENCES LTD. Other Non-Current Assets
ROIVANT SCIENCES LTD. (ROIV) had Other Non-Current Assets of $29.59 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Assets, Noncurrent $29.59M.
- 2026-03-31: Other Assets, Noncurrent $40.92M.
- 2025-12-31: Other Assets, Noncurrent $34.56M.
- 2025-09-30: Other Assets, Noncurrent $27.83M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $29.59M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $40.92M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $34.56M 10-Q · filed 2026-02-06 | |
| 2025-09-30 | $27.83M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $31.09M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $32.86M 10-K · filed 2026-05-20 | |
| 2024-12-31 | $33.88M 10-Q · filed 2025-02-10 | |
| 2024-09-30 | $36.90M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $32.81M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $37.70M 10-K · filed 2025-05-29 | $39.11M 10-K · filed 2024-05-30 |
| 2023-12-31 | $46.85M 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $49.80M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $46.31M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $49.48M 10-K · filed 2024-05-30 | |
| 2022-12-31 | $46.22M 10-Q · filed 2023-02-13 | |
| 2022-09-30 | $11.87M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $12.82M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $25.82M 10-K · filed 2023-06-28 | $16.09M 10-K · filed 2022-06-28 |
| 2021-12-31 | $20.88M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $21.34M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $26.52M 10-Q · filed 2021-09-21 | |
| 2021-03-31 | $27.20M 10-K · filed 2022-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |